Cullinan Therapeutics (CGEM) Earnings Date & Reports
Cullinan Therapeutics Inc is a biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
CGEM is expected to report earnings to rise 11.20% to -82 cents per share on August 07
Q2'25
Est.
$-0.82
Q1'25
Beat
by $0.08
Q4'24
Beat
by $0.06
Q3'24
Beat
by $0.10
Q2'24
Missed
by $0.02
The last earnings report on May 08 showed earnings per share of -74 cents, beating the estimate of -81 cents. With 62.03K shares outstanding, the current market capitalization sits at 457.95M.